NDC 53808-0661

CRIXIVAN

Indinavir Sulfate

CRIXIVAN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Indinavir Sulfate.

Product ID53808-0661_b34e05d5-b64b-42d0-a121-f5e21dfc3c1b
NDC53808-0661
Product TypeHuman Prescription Drug
Proprietary NameCRIXIVAN
Generic NameIndinavir Sulfate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-07-01
Marketing CategoryNDA / NDA
Application NumberNDA020685
Labeler NameState of Florida DOH Central Pharmacy
Substance NameINDINAVIR SULFATE
Active Ingredient Strength400 mg/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53808-0661-1

30 CAPSULE in 1 BLISTER PACK (53808-0661-1)
Marketing Start Date2009-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53808-0661-1 [53808066101]

CRIXIVAN CAPSULE
Marketing CategoryNDA
Application NumberNDA020685
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-07-01
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
INDINAVIR SULFATE400 mg/1

NDC Crossover Matching brand name "CRIXIVAN" or generic name "Indinavir Sulfate"

NDCBrand NameGeneric Name
0006-0571CRIXIVANindinavir sulfate
0006-0573CRIXIVANindinavir sulfate
21695-366CRIXIVANindinavir sulfate
53808-0661CRIXIVANindinavir sulfate

Trademark Results [CRIXIVAN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CRIXIVAN
CRIXIVAN
74194790 1933374 Live/Registered
MERCK SHARP & DOHME CORP.
1991-08-15
CRIXIVAN
CRIXIVAN
74000084 not registered Dead/Abandoned
MERCK & CO., INC.
1989-11-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.